Description
Atomoxetine is indicated for treating attention deficit hyperactivity disorder (ADHD) in adults and children over six years. Although atomoxetine is only FDA-approved for treating ADHD, it is sometimes used off-label to treat adult patients with treatment-resistant depression
| Strength | 10 mg |
| Pack Size | Not specified |
| Brand | Not specified |
| Packaging Type | Not specified |
| Composition | Not specified |
| Form | Not specified |
| Shelf Life | 24 Month |
| Usages | Not specified |
| Country of Origin | Made in India |
